Personalized medicine is an approach to care that tailors treatment to an individual patient rather than relying only on broad population guidelines. AI supports this by analyzing genomic profiles, biomarkers, and real-time health data to suggest more precise therapies or dosages. The result is often fewer side effects and better treatment fit.
Expanded Definition
Personalized medicine is a care model that uses patient-specific evidence to refine diagnosis, drug choice, dosing, and monitoring. In AI-enabled environments, that evidence may include genomics, biomarkers, imaging, medication history, and streaming health data. The point is not merely to make treatment “custom,” but to increase clinical fit while reducing avoidable harm.
Definitions vary across vendors and health systems because the term is sometimes used narrowly for precision therapeutics and sometimes broadly for any individualized care pathway. For governance purposes, NHI Management Group treats it as a decision-support pattern that must be clinically validated, traceable, and explainable. That distinction matters when a model proposes therapy changes based on data that are incomplete, biased, or not representative of the patient cohort. The same workflow also depends on tightly controlled access to medical records, lab integrations, and model APIs, which makes identity and secrets management part of the safety boundary. The NIST Cybersecurity Framework 2.0 is useful here because it frames data protection, access control, and recovery as operational requirements rather than optional IT features. The most common misapplication is treating personalized medicine as a generic AI recommendation engine, which occurs when clinicians accept model output without validating the patient data, provenance, and clinical context behind it.
Examples and Use Cases
Implementing personalized medicine rigorously often introduces governance and validation overhead, requiring organisations to weigh better treatment fit against higher data integration, privacy, and review costs.
- Oncology teams use tumor genomic profiles and biomarker panels to select targeted therapies, while AI helps rank options against prior outcomes and contraindications.
- Pharmacogenomics systems adjust dosing recommendations for drugs with narrow therapeutic windows, especially where metabolism differs by genotype.
- Remote monitoring programs combine wearable data, lab trends, and medication adherence signals to adapt care plans between visits.
- Clinical decision support platforms connect EHR data to model services, which requires the credential hygiene and access discipline discussed in the Ultimate Guide to NHIs.
- Research hospitals test cohort-specific models for rare diseases, then compare model performance against established guidance from the NIST Cybersecurity Framework 2.0 to ensure data flows and access paths remain controlled.
These use cases are strongest when clinicians can see why a recommendation changed, what data contributed to the result, and whether the system is operating within approved scope.
Why It Matters in NHI Security
Personalized medicine depends on a dense mesh of services, APIs, and machine identities that move protected health information and decision support data across systems. If those NHIs are over-privileged, unrotated, or poorly inventoried, the clinical benefit of personalization can be undermined by data exposure, model tampering, or unauthorized access to treatment workflows. NHI Management Group notes that only 5.7% of organisations have full visibility into their service accounts, while 97% of NHIs carry excessive privileges, which makes healthcare a particularly exposed environment when AI pipelines are involved. The operational lesson is that personalization is not just a clinical model problem; it is also an identity governance problem, especially when model services consume secrets stored in CI/CD systems, vaults, or external health data platforms. The Ultimate Guide to NHIs is relevant because it ties visibility, rotation, and offboarding to the practical control of machine-driven access. The most pressing failure mode is not a theoretical privacy debate, but a compromised integration or leaked credential that changes how treatment recommendations are generated. Organisations typically encounter the need for personalized medicine governance only after an access incident, a model drift event, or a data exposure, at which point the term becomes operationally unavoidable to address.
Standards & Framework Alignment
This section maps relevant standards and security frameworks to the operational risks and controls described in this guidance.
OWASP Non-Human Identity Top 10 address the attack and risk surface, while NIST AI RMF, NIST CSF 2.0, NIST Zero Trust (SP 800-207) and NIST SP 800-63 set the governance and control requirements practitioners need to meet.
| Framework | Control / Reference | Relevance |
|---|---|---|
| NIST AI RMF | Personalized medicine relies on risk-managed AI decisions in safety-critical clinical contexts. | |
| NIST CSF 2.0 | PR.AC | Patient data and model services require controlled access and least privilege. |
| NIST Zero Trust (SP 800-207) | Healthcare AI pipelines benefit from continuous verification of users, devices, and services. | |
| OWASP Non-Human Identity Top 10 | NHI-02 | Model and data services depend on secure handling of machine credentials and secrets. |
| NIST SP 800-63 | AAL2 | Higher-assurance authentication is relevant when clinicians access sensitive personalized care systems. |
Document data quality, explainability, and human oversight before using AI to influence patient care.
Related resources from NHI Mgmt Group
- How should teams run personalized phishing training without overexposing employee data?
- Who is accountable when personalized flows create discrimination or abuse risk?
- What is the difference between a personal fork and a supported personalized configuration?
- Why do shared caches create risk when authenticated or personalized responses are involved?
Deepen Your Knowledge
Reviewed and updated by the NHIMG editorial team on August 27, 2026.
NHI Mgmt Group — the #1 independent authority on Non-Human Identity, IAM, and Agentic AI security. nhimg.org
